Recent advances in the diagnostic methods and therapeutic strategies of transthyretin cardiac amyloidosis

doi:10.4330/wjc.v16.i7.370

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 7

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1607)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

HTML

924

Figures (1-1)

117

Tables (1-1)

102

Sum=1178

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

122

Sum=214

Publishing Process of This Article

Item

Count

Browse

Download

Sum=97

Jul 26, 2024 (publication date) through Nov 20, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Cardiology

ISSN

1949-8462

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Cardiol. Jul 26, 2024; 16(7): 370-379
Published online Jul 26, 2024. doi: 10.4330/wjc.v16.i7.370

Open in New Tab Full Size Figure Download Figure

Figure 1 Diagnostic approach and therapeutic strategies in transthyretin amyloidosis cardiac amyloidosis. ACEi: Angiotensin-converting enzyme inhibitors; AL: Immunoglobulin light chain amyloidosis; ARBs: Angiotensin receptor blockers; ATTR: Transthyretin amyloidosis; ATTRv: Mutant variant transthyretin amyloidosis; ATTRwt: Wild type transthyretin amyloidosis; AV: Atrioventricular; CMR: Cardiac magnetic resonance; ECG: Electrocardiogram; HCL: Heart/contralateral; HF: Heart failure; LV: Left ventricular; LVH: Left ventricular hypertrophy; RV: Right ventricular; sFLC: Serum free light chain; SGLT2i: Sodium-glucose cotransporter-2 inhibitors; SIFE: Serum immunofixation electrophoresis; SPECT: Single-photon emission computed tomography; UIFE: Urine immunofixation electrophoresis.

Citation: Kourek C, Briasoulis A, Magouliotis DE, Georgoulias P, Giamouzis G, Triposkiadis F, Skoularigis J, Xanthopoulos A. Recent advances in the diagnostic methods and therapeutic strategies of transthyretin cardiac amyloidosis. World J Cardiol 2024; 16(7): 370-379
URL: https://www.wjgnet.com/1949-8462/full/v16/i7/370.htm
DOI: https://dx.doi.org/10.4330/wjc.v16.i7.370